FIELD: medicine.
SUBSTANCE: invention concerns medicine, be more specific to oncology, and concerns the substances stimulating maturing of dendritic cells (DC). Application of fucoidan from Fucus evanescens or polysaccharide composition from Fucus evanescens consisting of fucoidan in amount of 60-80% and poly-mannuronic acid in amount of 20-40%, as an agent possessing ability to induce maturing of dendritic cells is offered. The declared fucoidan preparations have a standardised composition and, hence, possess direct biological effect. They keep the properties for long time (3 years).
EFFECT: increase of DC functional activity under the influence of the declared substances.
8 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING AUTOLOGOUS DENDRITIC CELLS WITH HIGH LEVEL OF EXPRESSION OF HLA-DR AND COSTIMULATORY MOLECULES IN ONCOLOGICAL DISEASES | 2020 |
|
RU2767631C1 |
COMPOSITION FOR STIMULATING DENDRITIC CELL MATURATION, CONTAINING HYBRID PROTEIN RV2299C/ESAT-6 | 2017 |
|
RU2733886C2 |
TORK PROTEIN KINASE INHIBITOR WITH DIRECTED CHEMOPREVENTIVE EFFECT IN VITRO | 2014 |
|
RU2566268C1 |
AGENTS AND METHODS BASED ON USING FIBRONECTIN OF DOMAIN EDA | 2006 |
|
RU2430738C2 |
METHOD FOR PRODUCING REGULATORY DENDRITIC CELLS | 2011 |
|
RU2597976C2 |
BIOLOGICALLY ACTIVE PRODUCT FROM BROWN ALGAE, BIOLOGICALLY ACTIVE FOOD SUPPLEMENT, SOFT DRINK, PERFUME AND COSMETIC AGENT | 2006 |
|
RU2315487C1 |
SYSTEM AND METHOD OF OBTAINING AND STORAGE OF ACTIVATED MATURE DENDRITIC CELLS | 2011 |
|
RU2575978C2 |
METHOD FOR ASSESSING THE SENSITIVITY OF A TUMOR TO IMMUNO-ONCOLOGICAL DRUGS | 2021 |
|
RU2771760C1 |
APPLICATION OF INHIBITING TGF-beta1 PEPTIDES FOR PREPARATION OF AGENT MODULATING IMMUNE RESPONSE | 2005 |
|
RU2420307C2 |
COMPOSITIONS AND METHODS FOR USING CA9 PROTEIN FOR IMMUNE SYSTEM STIMULATION | 2008 |
|
RU2497543C2 |
Authors
Dates
2009-07-20—Published
2008-02-18—Filed